Company News for May 27, 2011 - Corporate Summary
27 May 2011 - 7:05PM
Zacks
• Big Lots, Inc. (NYSE:BIG) reported Q1 EPS of
$0.70, above the Zacks Consensus Estimates of $0.68 per share.
Revenues for the quarter fell 0.6% year-over-year to $1.23 billion,
lower than the Zacks Consensus Estimate of $1.276 billion
• TD Bank Group (NYSE:TD) announced Q2 EPS of
$1.62, lower than the Zacks Consensus Estimate of $1.66 per share.
Revenues for the quarter grew 7.5% year-over-year to $5.23 billion,
falling short of the Zacks Consensus Estimate of $5.355 billion
• Tiffany & Co. (NYSE:TIF) posted Q1 EPS of
$0.63, higher than the Zacks Consensus Estimate of $0.57. Revenues
for the quarter grew 20% year-over-year to $761 million, beating
the Zacks Consensus Estimate of $701 million
• H.J. Heinz Company (NYSE:HNZ) announced Q4 EPS
of $0.69, lower than the Zacks Consensus Estimate of $0.72 per
share. Revenues for the quarter grew 6% year-over-year to $2.89
billion, above the Zacks Consensus Estimate of $2.872 billion
• Canaccord Genuity initiated coverage on AcelRx
Pharmaceuticals Inc (NASDAQ:ACRX) with a "Buy" rating and set a
target price of $6.00 on the stock
• Ladenburg Thalmann initiated coverage on
American Water Works Co., Inc. (NYSE:AWK) with a “Neutral” rating
and a target price of $31.00
• Global Hunter Securities initiated coverage on
Trius Therapeutics Inc (NASDAQ:TSRX) with a “Buy” rating along with
a target price of $11.00
• Analysts at BMO Capital Markets downgraded
Diamond Foods (NASDAQ:DMND) to "Market Perform" rating from an
“Outperform” rating
• JPMorgan Chase & Co. (NYSE:JPM) downgraded
Gen-Probe Incorporated (NASDAQ:GPRO) to “Neutral” rating from
“Overweight” rating with a target price of $85.00
• Goldman Sachs (NYSE:GS) downgraded RadioShack
(NYSE:RSH) to “Neutral” rating from “Buy” rating with a target
price of $17.00
ACELRX PHARMACT (ACRX): Free Stock Analysis Report
AMER WATER WORK (AWK): Free Stock Analysis Report
BIG LOTS INC (BIG): Free Stock Analysis Report
DIAMOND FOODS (DMND): Free Stock Analysis Report
GEN-PROBE INC (GPRO): Free Stock Analysis Report
GOLDMAN SACHS (GS): Free Stock Analysis Report
HEINZ (HJ) CO (HNZ): Free Stock Analysis Report
JPMORGAN CHASE (JPM): Free Stock Analysis Report
RADIOSHACK CORP (RSH): Free Stock Analysis Report
TORONTO DOM BNK (TD): Free Stock Analysis Report
TIFFANY & CO (TIF): Free Stock Analysis Report
TRIUS THERAPEUT (TSRX): Free Stock Analysis Report
Zacks Investment Research
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Oct 2023 to Oct 2024